Sign In
Buy SNSS
$5.32
+0 (+0%)
At Close: May 27, 2022
SNSS Stock Price Increased Over 65% Intraday: Why It Happened
10:48am, Wednesday, 24'th Feb 2021
The stock price of Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) increased by over 65% during intraday trading. This is why it happened.
SNSS Stock: Why Sunesis Pharmaceuticals Is Soaring Today
03:05pm, Tuesday, 23'rd Feb 2021
An analyst upgrade is the near-term catalyst, but for Sunesis Pharmaceuticals, it's really about patents in oncology and an impending merger with Viracta. The post SNSS Stock: Why Sunesis Pharmaceutic
SNSS Stock Price Increased Over 46% Intraday: Why It Happened
12:22pm, Tuesday, 23'rd Feb 2021
The stock price of Sunesis Pharmaceuticals, Inc (NASDAQ: SNSS) increased by over 46% during intraday trading. This is why it happened.
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Sunesis Pharmaceuticals, Inc. - SNSS
09:13pm, Friday, 04'th Dec 2020
NEW YORK, Dec. 4, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York Ci
SHAREHOLDER ALERT: WeissLaw LLP Investigates Sunesis Pharmaceuticals, Inc.
08:34pm, Monday, 30'th Nov 2020
NEW YORK, Nov. 30, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Sunesis Pharmaceuticals, Inc. ("Sunes
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) and Viracta Therapeutics, Inc. is fa
Sunesis Pharmaceuticals News: 7 Things for SNSS Stock Investors to Know About the Viracta Deal
11:25am, Monday, 30'th Nov 2020
Shares of SNSS stock are climbing higher on Monday after Sunesis Pharmaceuticals announced a merger deal with Viracta Therapeutics. The post Sunesis Pharmaceuticals News: 7 Things for SNSS Stock Inves
Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement
07:30am, Monday, 30'th Nov 2020
Merger to c reate Nasdaq-listed company focused on developing Viracta's precision oncology pipeline targeting virus-associated malignancies
Sunesis Pharmaceuticals, Inc. (SNSS) Q3 2020 Results - Earnings Call Transcript
06:14pm, Monday, 16'th Nov 2020
Sunesis Pharmaceuticals, Inc. (SNSS) Q3 2020 Results - Earnings Call Transcript
Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent Highlights
04:05pm, Monday, 16'th Nov 2020
Sunesis to Host Conference Call Today at 4:30 PM Eastern Time Sunesis to Host Conference Call Today at 4:30 PM Eastern Time
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Monday, November 16th, 2020 at 4:30p
